James J. Choi

James J. Choi

Auto-generated profile, based on publicly available information

James J. Choi

Department of Bioengineering, Imperial College London, London, SW7 2AZ, UK

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
JCJames J. Choi
James J. Choi
MPMathieu Pernot
Mathieu Pernot
SSScott A. Small
Scott A. Small
EKElisa E. Konofagou
Elisa E. Konofagou

20 October 2009 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
JCJames J. Choi
James J. Choi
JFJameel A. Feshitan
Jameel A. Feshitan
BBBabak Baseri
Babak Baseri
SWShougang Wang
Shougang Wang
YTYao-Sheng Tung
Yao-Sheng Tung
EKElisa Konofagou
Elisa Konofagou
The therapeutic efficacy of neurological agents is severely limited, because large compounds do not cross the blood-brain barrier (BBB). Focused ultrasound (FUS) sonication in the presence of microbubbles has been shown to temporarily open the BBB, allowing systemically administered agents into the brain. Until now, polydispersed microbubbles (1-10 ¿m in diameter) were used, and, therefore, the bubble sizes better suited for inducing the opening remain unknown. Here, the FUS-induced BBB opening dependence on microbubble size is investigated. Bubbles at 1-2 and 4-5 ¿m in diameter were separately size-isolated using differential centrifugation before being systemically administered in mice ( n = 28). The BBB opening pressure threshold was identified by varying the peak-rarefactional pressure amplitude. BBB opening was determined by fluorescence enhancement due to systemically administered, fluorescent-tagged, 3-kDa dextran. The identified threshold fell between 0.30 and 0.46 MPa in the case of 1-2 ¿m bubbles and between 0.15 and 0.30 MPa in the 4-5 ¿m case. At every pressure studied, the fluorescence was greater with the 4-5 ¿m than with the 1-2 ¿m bubbles. At 0.61 MPa, in the 1-2 ¿m bubble case, the fluorescence amount and area were greater in the thalamus than in the hippocampus. In conclusion, it was determined that the FUS-induced BBB opening was dependent on both the size distribution in the injected microbubble volume and the brain region targeted.

29 September 2010 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
YTYao-Sheng Tung
Yao-Sheng Tung
FVFotios Vlachos
Fotios Vlachos
JCJames J Choi
James J Choi
TDThomas Deffieux
Thomas Deffieux
KSKirsten Selert
Kirsten Selert
EKElisa Konofagou
Elisa Konofagou
The in vivo cavitation response associated with blood-brain barrier (BBB) opening as induced by transcranial focused ultrasound (FUS) in conjunction with microbubbles was studied in order to better identify the underlying mechanism in its noninvasive application. A cylindrically focused hydrophone, confocal with the FUS transducer, was used as a passive cavitation detector (PCD) to identify the threshold of inertial cavitation (IC) in the presence of Definity® microbubbles (mean diameter range: 1.1-3.3 µm, Lantheus Medical Imaging, MA, USA). A vessel phantom was first used to determine the reliability of the PCD prior to in vivo use. A cerebral blood vessel was simulated by generating a cylindrical channel of 610 µm in diameter inside a polyacrylamide gel and by saturating its volume with microbubbles. The microbubbles were sonicated through an excised mouse skull. Second, the same PCD setup was employed for in vivo noninvasive (i.e. transdermal and transcranial) cavitation detection during BBB opening. After the intravenous administration of Definity® microbubbles, pulsed FUS was applied (frequency: 1.525 or 1.5 MHz, peak-rarefactional pressure: 0.15-0.60 MPa, duty cycle: 20%, PRF: 10 Hz, duration: 1 min with a 30 s interval) to the right hippocampus of twenty-six (n = 26) mice in vivo through intact scalp and skull. T1 and T2-weighted MR images were used to verify the BBB opening. A spectrogram was generated at each pressure in order to detect the IC onset and duration. The threshold of BBB opening was found to be at a 0.30 MPa peak-rarefactional pressure in vivo. Both the phantom and in vivo studies indicated that the IC pressure threshold had a peak-rarefactional amplitude of 0.45 MPa. This indicated that BBB opening may not require IC at or near the threshold. Histological analysis showed that BBB opening could be induced without any cellular damage at 0.30 and 0.45 MPa. In conclusion, the cavitation response could be detected without craniotomy in mice and IC may not be required for BBB opening at relatively low pressures.

1 January 2010 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
JCJames J. Choi
James J. Choi
SWShougang Wang
Shougang Wang
YTYao-Sheng Tung
Yao-Sheng Tung
BMBarclay Morrison
Barclay Morrison
EKElisa Konofagou
Elisa Konofagou

1 May 2012 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
EKElisa Konofagou
Elisa Konofagou
YTYao-Sheng Tunga
Yao-Sheng Tunga
JCJames Choia
James Choia
TDThomas Deffieuxa
Thomas Deffieuxa
BBBabak Baseria
Babak Baseria
FVFotios Vlachosa
Fotios Vlachosa
Over 4 million U.S. men and women suffer from Alzheimer's disease; 1 million from Parkinson's disease; 350,000 from multiple sclerosis (MS); and 20,000 from amyotrophic lateral sclerosis (ALS). Worldwide, these four diseases account for more than 20 million patients. In addition, aging greatly increases the risk of neurodegenerative disease. Although great progress has been made in recent years toward understanding of these diseases, few effective treatments and no cures are currently available. This is mainly due to the impermeability of the blood-brain barrier (BBB) that allows only 5% of the 7000 small-molecule drugs available to treat only a tiny fraction of these diseases. On the other hand, safe and localized opening of the BBB has been proven to present a significant challenge. Of the methods used for BBB disruption shown to be effective, Focused Ultrasound (FUS), in conjunction with microbubbles, is the only technique that can induce localized BBB opening noninvasively and regionally. FUS may thus have a huge impact in trans-BBB brain drug delivery. The primary objective in this paper is to elucidate the interactions between ultrasound, microbubbles and the local microenvironment during BBB opening with FUS, which are responsible for inducing the BBB disruption. The mechanism of the BBB opening in vivo is monitored through the MRI and passive cavitation detection (PCD), and the safety of BBB disruption is assessed using H&E histology at distinct pressures, pulse lengths and microbubble diameters. It is hereby shown that the BBB can be disrupted safely and transiently under specific acoustic pressures (under 0.45 MPa) and microbubble (diameter under 8 μm) conditions.

1 September 2010 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
BBBabak Baseri
Babak Baseri
JCJames J. Choi
James J. Choi
YTYao-Sheng Tung
Yao-Sheng Tung
EKElisa Konofagou
Elisa Konofagou